Concert Pharmaceuticals (NASDAQ: CNCE)
Some price data may be temporarily unavailable.
Concert Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Concert Pharmaceuticals Company Info
Concert Pharmaceuticals is a clinical-stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium. Concert applies its innovative precision deuterium chemistry platform to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with the potential for efficacy and safety, while greatly reducing R&D risk, time, and expense.
News & Analysis
Why Concert Pharmaceuticals Stock Rocketed Higher This Week
The company is changing hands in a deal worth at least $576 million.
Why Concert Pharmaceuticals Stock Cratered Today
The company's experimental schizophrenia drug flopped in a phase 2 study.
Why Concert Pharmaceuticals Stock Is Tanking Today
Shares fall hard after a late-stage trial comes up short.
Why Concert Pharmaceuticals, Inc. Is Singing the Blues Today
Bad news trumps good news for the biotech.
Why General Electric, Concert Pharmaceuticals, and NVR Jumped Today
Even on a quiet day on Wall Street, these stocks posted gains. Find out why.
3 Biotech Stocks to Buy in March
Why Spark Therapeutics, Albany Molecular Research, and Concert Pharmaceuticals could be great biotech stocks to buy as spring approaches.
Why Concert Pharmaceuticals Stock Is Soaring Today
The pharma cut a deal with Vertex for the experimental experimental cystic fibrosis drug CTP-656.
Vertex Turns Up the Heat on Cystic Fibrosis Challengers
With two new correctors entering clinical development, Vertex is about to leave Galapagos and Concert in the dust.
Valuation
Earnings Transcripts
Concert Pharmaceuticals, inc (CNCE) Q3 2021 Earnings Call Transcript
CNCE earnings call for the period ending September 30, 2021.
Concert Pharmaceuticals, inc (CNCE) Q2 2021 Earnings Call Transcript
CNCE earnings call for the period ending June 30, 2021.
Concert Pharmaceuticals, Inc. (CNCE) Q1 2021 Earnings Call Transcript
CNCE earnings call for the period ending April 30, 2021.
Concert Pharmaceuticals, Inc. (CNCE) Q4 2020 Earnings Call Transcript
CNCE earnings call for the period ending December 31, 2020.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.